Tampa Bay Business Journal – May 31
Moffitt's existing hospital has roughly 200 beds and it is at capacity, Moffitt CEO and President Dr. Alan List said, stating the hospital saw 65,000 patients last year.
WJCT – May 30
A $265,000 grant was awarded for Cadw Therapeutics LLC, The Moffitt Cancer Center and Research Institute and SpacePharma R&D Israel to test human stress and the impact of space on human DNA
Cure – May 29
While still completing standard of care, which is radiation and chemo, my family set out to find help and did so through a double-blind study at the Moffitt Cancer Center in Tampa, Florida; while it offered hope, the treatment hurt so badly I almost quit.
Tampa Bay Newspapers – May 29
Moffitt Cancer Center and AdventHealth are working together to open an outpatient cancer center on the campus of AdventHealth Wesley Chapel in Pasco County.
PR Newswire – May 29
Moffitt Cancer Center announced today a licensing agreement with TuHURA Biopharma, Inc., a start-up biotechnology company in Seattle, to develop new immunotherapy treatments for cancer that will apply to a greater number of cancers and a larger patient population.
WOGX – May 28
The grants included $250,000 for the Harris Corp. and Nano Dimension Israel to develop 3D printing materials that can survive in the harshness of space, a proposal expected to lower the manufacturing cost of small-satellites; $265,000 grant for Cadw Therapeutics LLC, The Moffitt Cancer Center and Research Institute and SpacePharma R&D Israel to test human stress and the impact of space on human DNA; $250,000 for Semplastics EHC LLC of Oviedo, and Polymertal LTD Israel to develop “a novel class of hybrid materials, suitable for aviation, and space applications, ranging from structural parts to electronic assemblies.”
Suncoast News Network – May 28
She found she has three more tumors in her spine while working with doctors at Moffitt Cancer Center.
Lymphoma News Today – May 28
The team, led by Jianguo Tao, MD, PhD, from the Moffitt Cancer Center, and Jun Qi, PhD, from the Dana-Farber Cancer Institute, were interested in looking at how B-cell lymphomas, such as mantle cell lymphoma (MCL) and double-hit lymphoma (DHL) could develop resistance to venetoclax.
Targeted Oncology – May 24
In addition, Komrokji, a senior member of the Malignant Hematology and Experimental Therapeutics Program and head of the Leukemia and Myelodysplastic Syndrome Section and vice chair of the Malignant Hematology Department at the Moffitt Cancer Center, discussed treatment options based on the case scenario of a patient with myelofibrosis (MF).
Healio – May 24
In this installment of In Practice, Julio C. Chavez, MD, assistant member in the lymphoma section of the department of malignant hematology at Moffitt Cancer Center, will discuss the challenges and best practices when preparing patients and their community oncologist for departure from the cell therapy clinic and back to the community setting.
STAT – May 24
A longtime lobbyist in Tallahassee, who I don’t even know but who follows me on Twitter — I tweet often about cancer and also health care topics that I’m writing about — he knew the founder of Moffitt Cancer Center, H. Lee Moffitt, and called him.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.